Premier Biomedical Financials
| BIEI Stock | USD 0.0008 0.0001 11.11% |
Premier |
Understanding current and past Premier Biomedical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Premier Biomedical's financial statements are interrelated, with each one affecting the others. For example, an increase in Premier Biomedical's assets may result in an increase in income on the income statement.
Premier Biomedical Stock Summary
Premier Biomedical competes with Grey Cloak. Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania. Premier Biomedical is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US74048K2033 |
| Business Address | PO Box 25, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.premierbiomedical.com |
| Phone | 724 633 7033 |
| Currency | USD - US Dollar |
Premier Biomedical Key Financial Ratios
Premier Biomedical's financial ratios allow both analysts and investors to convert raw data from Premier Biomedical's financial statements into concise, actionable information that can be used to evaluate the performance of Premier Biomedical over time and compare it to other companies across industries.| Return On Asset | -1.54 | |||
| Number Of Employees | 11 | |||
| Beta | -4.63 | |||
| Z Score | -40.0 |
Premier Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Premier Biomedical's current stock value. Our valuation model uses many indicators to compare Premier Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Premier Biomedical competition to find correlations between indicators driving Premier Biomedical's intrinsic value. More Info.Premier Biomedical is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Premier Biomedical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Premier Biomedical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Premier Biomedical Systematic Risk
Premier Biomedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Premier Biomedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Premier Biomedical correlated with the market. If Beta is less than 0 Premier Biomedical generally moves in the opposite direction as compared to the market. If Premier Biomedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Premier Biomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Premier Biomedical is generally in the same direction as the market. If Beta > 1 Premier Biomedical moves generally in the same direction as, but more than the movement of the benchmark.
Premier Biomedical December 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Premier Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Premier Biomedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Premier Biomedical based on widely used predictive technical indicators. In general, we focus on analyzing Premier Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Premier Biomedical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 40.4 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 11.11 |
Complementary Tools for Premier Pink Sheet analysis
When running Premier Biomedical's price analysis, check to measure Premier Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Premier Biomedical is operating at the current time. Most of Premier Biomedical's value examination focuses on studying past and present price action to predict the probability of Premier Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Premier Biomedical's price. Additionally, you may evaluate how the addition of Premier Biomedical to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |